Back

Go back

What products will remain within Pfizer PAP as of January 1, 2024?

Question

Answer

Type	Primary Care	Specialty Care	Oncology
Medicines	Celontin Depo-Estradiol Duavee Estring Norpace CR Nurtec Premarin Premphase Prempro Synarel Tikosyn Trecator Zarontin Zavzpret	BeneFIX Cibinqo Elelyso Eucrisa Litfulo Somavert Vyndaqel / Vyndamax Xeljanz Xyntha	Besponsa Bosulif Braftovi Daurismo Ibrance Inlyta Lorbrena Mektovi Mylotarg Talzenna Vizimpro Xalkori
Vaccines	Abrysvo Prevnar 13 Prevnar 20 Trumenba

updates

20